Department of Health Technology Assessment and Health Economics, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
Centre for Health Economics, University of York, York, UK.
Expert Rev Pharmacoecon Outcomes Res. 2023 Mar;23(3):353-363. doi: 10.1080/14737167.2023.2171989. Epub 2023 Jan 31.
To estimate the budget impact of covering the FreeStyle Libre Flash Continuous Glucose Monitoring System (FSL) for type 1 Diabetes Mellitus patients (T1DM), compared to self-monitoring of blood glucose (SMBG), from the perspective of public and private third-party payers in Chile.
A budget impact model was developed to estimate the cost difference between SMBG and FSL over five years. Two FSL coverage schemes were assessed. Input parameters were retrieved from the literature review and complemented by expert opinion. Healthcare costs were estimated by a micro-costing approach and reported in USD.
For a public sector third-party payer, incorporating FSL implied a cost increase up to USD 0.013 per member per month (PMPM) for the fifth year under the broad coverage scheme and a net saving of 0.0001 PMPM (all years) under the restricted coverage scheme. From a private sector third-party payer, incorporating FSL implied savings up to USD 0.028 PMPM (fifth year) for the broad coverage scheme and up to USD 0.012 PMPM (fifth year) for the restricted scheme.
Incorporating the FSL for T1DM patients was associated with a marginal incremental cost for the public sector third-party payer and cost savings in Chile's private healthcare sector.
从智利公共和私人第三方支付者的角度出发，估算涵盖 1 型糖尿病（T1DM）患者使用 FreeStyle Libre Flash 连续血糖监测系统（FSL）相对于自我血糖监测（SMBG）的预算影响。
开发了一个预算影响模型，以估算 SMBG 和 FSL 在五年内的成本差异。评估了两种 FSL 覆盖方案。输入参数从文献综述中检索，并由专家意见补充。医疗保健成本采用微观成本法估算，并以美元表示。
对于公共部门第三方支付者，采用广泛覆盖方案，第五年每个成员每月（PMPM）的 FSL 纳入将导致成本增加 0.013 美元，而采用限制覆盖方案，每年的净节省为 0.0001 PMPM。对于私人部门第三方支付者，采用广泛覆盖方案，第五年 FSL 的纳入将导致成本节省最高可达 0.028 美元/每个成员每月，采用限制覆盖方案，第五年的成本节省最高可达 0.012 美元/每个成员每月。
对于 T1DM 患者而言，纳入 FSL 可能会导致公共部门第三方支付者的边际增量成本增加，但在智利私人医疗保健部门会产生成本节约。
